Sti 2018 Lse
Sti 2018 Lse
Sti 2018 Lse
Infections
Dr Harinarayan Radhakrishna
FoCP / ICP 23/11/2018
Plan
Learning outcomes
Sexual history taking
Urethritis – gonococcal, chlamydia, non-gonococcal
Genital ulcers – Herpes, Syphilis, Lymphogranuloma
venereum
Learning Outcomes
• Demonstrate knowledge and understanding of the
range of presentation of STIs
• Demonstrate the ability to construct a plan for the
initial management of a patient presenting with
possible STI: including relevant contact history;
investigation and treatment.
CORE CONDITIONS:
UTI, Systemic Infection [any cause]
CORE PRESENTATIONS
Difficult micturition and dysuria,
Infection [symptoms of]
Lymphadenopathy
Scenario
• A 25 year - old male presents to your GUM clinic with urethral
discharge and painful micturition.
Source: BASHH
Urethritis
Symptoms: Discharge per urethra, dysuria, urethral itching, orchalgia
Signs: Urethral discharge, meatitis
Transmission: Sexually acquired in the majority of (but not all) cases.
Aetiology:
Gonococcal urethritis (GCU) Non-gonococcal urethritis (NGCU)
Neisseria gonorrhoeae Chlamydia trachomatis
Mycoplasma genitalium
Ureaplasma urealyticum
Herpes Simplex Virus (HSV)
Trichomonas vaginalis (TV)
Urethritis
Diagnosis & Investigations
• A mucopurulent or purulent urethral discharge
• Urethral smear - five leukocytes per oil immersion field on microscopy
• First-voided urine specimen that demonstrates leukocyte esterase on
dipstick test or at least 10 WBCs per high-power field on microscopy
• All patients with urethritis should be tested for Neisseria
gonorrhoeae and Chlamydia trachomatis.
• Urethral smear gram-negative diplococci on gram stain. (N. gonorrhoeae)
• Urethral culture for N gonorrhoeae and C trachomatis
• Nucleic acid amplification tests (NAAT) for gonococcal
urethritis, Chlamydia, Mycoplasma species, Ureaplasma species, and T
vaginalis
Urethritis
Diagnosis & Investigations
• A mucopurulent or purulent urethral discharge
• Urethral smear - five leukocytes per oil immersion field on
microscopy
• First-voided urine specimen that demonstrates leukocyte
esterase on dipstick test or at least 10 WBCs per high-power field
on microscopy
• All patients with urethritis should be tested for Neisseria
gonorrhoeae and Chlamydia trachomatis.
• Urethral smear gram-negative diplococci on gram stain. (N.
gonorrhoeae)
Urethritis
Diagnosis & Investigations
• Urethral culture for N gonorrhoeae and C trachomatis
• Nucleic acid amplification tests (NAAT) for gonococcal
urethritis, Chlamydia,
Mycoplasma species, Ureaplasma species, and T vaginalis
• Other STIs testing – HSV, syphilis and HIV serology
• Nasopharyngeal and/or rectal
• Pregnancy testing: Women who have had unprotected
intercourse
Urethritis
Treatment of non-gonococcal urethritis
• Doxycycline 100mg twice daily PO for 7 days or
Azithromycin 500mg stat then 250mg once daily PO for the
next four days.
Types
1. Early Latency (First year after infection)
2. Late Latency (Latent infection >1 year)
• No symptoms of primary or secondary syphilis
• Only infectious in pregnancy and transfusion
Late / Tertiary Syphilis
Slowly progressive, may affect any organ. The
disease is generally not thought to be infectious
at this stage.
Divided into gummatous, cardiovascular and
neurological complications.
Pathophysiology
• Low-level syphilis infection with strong immune
response
Tertiary Syphilis - Gumma
Management of syphilis:
Investigations
• Dark ground microscopy
• Polymerase chain reaction
• Treponemal EIA/CLIA
• Venereal Disease Research Laboratory (VDRL)
• Rapid Plasma Reagin (RPR)
• Automated Reagin Test (ART)
• Standard Test for Syphilis (STS)
• Fluorescent Treponemal Antibody (FTA-ABS)
• Microhemagglutination - Treponema pallidum (MHA-TP)
• Confirmation of positive Screening Test - Fluorescent Treponemal Antibody (FTA-
ABS)
• Lumbar Puncture with CSF Exam for neurosyphilis
• Screening for coincident STIs
Treatment
Early syphilis (primary, secondary and early latent)
• Benzathine penicillin G 2.4 MU IM single dose
Late latent, cardiovascular and gummatous syphilis
• Benzathine penicillin 2.4 MU IM weekly for three weeks (three doses)
Neurosyphilis including neurological/ophthalmic involvement in early
syphilis
• Procaine penicillin 1.8 MU–2.4 MU IM OD plus probenecid 500mg PO
QID for 14 days OR
• Benzylpenicillin 10.8–14.4g daily, given as 1.8–2.4g IV every 4h for 14
days
Treatment
• Other preventive measures, advice, partner
notification, screening.
Lymphogranuloma venereum (LGV)
• Caused by one of three invasive serovars (L1, L2 or L3)
of Chlamydia trachomatis, though L2 is the most
common strain involved.
• Characterized by self-limiting genital papules or ulcers
followed by painful inguinal and/or femoral
lymphadenopathy.
• Transmission: direct contact with the skin or mucous
membranes of an infected partner. Does not
penetrate intact skin.
Lymphogranuloma venereum (LGV)
Clinical features
3 stages:
First stage (Primary LGV)
• Incubation period: 3-30 days.
• Small, painless papule or pustule that may erode to form a small,
asymptomatic herpetiform ulcer that usually heals rapidly without
scarring.
• Men: coronal sulcus, prepuce, glans, and scrotum.
• Rarely, urethritis.
• Women: posterior vaginal wall, posterior cervix, fourchette, and
vulva.
• The initial lesion, especially in women, often goes unnoticed by the
patient.
Lymphogranuloma venereum (LGV)
Clinical features
Second stage (secondary LGV)
• Begins 2-6 weeks after the primary lesion.
• Painful regional lymphadenopathy (usually in the inguinal and/or
femoral lymph nodes).
• Painful, swollen lymph nodes coalesce to form buboes, which may
rupture or harden, then slowly resolve.
• Inguinal lymphadenopathy (esp. males), deep iliac or perirectal nodes
involvement (females) - may only present with non-specific back
and/or abdominal pain.
• Constitutional symptoms.
Inguinal and femoral lymphadenopathy of 2nd stage LGV showing ‘Groove sign’
Lymphogranuloma venereum (LGV)
Clinical features
Second stage (secondary LGV)
• Systemic spread may lead to the following conditions:
Arthritis
Ocular inflammatory disease
Cardiac involvement
Pulmonary involvement
Aseptic meningitis
Hepatitis or perihepatitis
Lymphogranuloma venereum (LGV)
Clinical features
Third stage (tertiary LGV)
• ‘Genitoanorectal syndrome’.
• More common in women.
• Characterized by proctocolitis.
• Symptoms include the following conditions:
Bloody purulent discharge
Rectal pain
Tenesmus
Lymphogranuloma venereum (LGV)
Complications
• Destruction of lymph nodes may result in genital
lymphoedema (elephantiasis) with persistent
suppuration and pyoderma.
• An association with rectal cancer has been
reported.
Lymphogranuloma venereum (LGV)
Investigations
• Nucleic acid amplification tests (NAAT)
• Rectal polymorphonuclear leucocytes (PMNLs)
from rectal swabs in LGV proctitis
• Urethral swab or first-catch urine specimen for
urethritis
• Screening for coincident STIs
Lymphogranuloma venereum (LGV)
Treatment
•Doxycycline 100 mg twice daily PO for 21
days or Tetracycline 2 g daily PO for 21 days
•Other preventive measures, advice, partner
notification, screening.
Further reading
• Genital warts – HPV
• Bacterial vaginosis
• Vulvovaginal candidiasis
• Scabies
Useful Resources
• British Association for Sexual Health and HIV
https://www.bashh.org/guidelines